Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is a malignant carcinoma with high rate of mortality. The current treatment is ineffective with poor survival time. Therefore, there is an urgent need for effective therapeutic drug regimens. The multi‐target tyrosine kinase inhibitor (TKI) anlotinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shanshan, Ge, Yang, Liu, Jian, Liu, Heshu, Yan, Rui, Gao, Tianbo, Fan, Xiaona, Xiao, Zeru, An, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529129/
https://www.ncbi.nlm.nih.gov/pubmed/34462984
http://dx.doi.org/10.1002/jcla.23986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529129/
https://www.ncbi.nlm.nih.gov/pubmed/34462984
http://dx.doi.org/10.1002/jcla.23986

Ejemplares similares